Deutsch English Français

Contact

EP2591114

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2591114

EP2591114 - IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA [Right-click to bookmark this link]
Status	Patent revoked Status updated on 22.02.2023 Database last updated on 03.04.2025
Most recent event Tooltip	24.02.2023	Revocation of patent	published on 29.03.2023 [2023/13]
Applicant(s)	For all designated states GlaxoSmithKline Biologicals SA Rue de l'Institut 89 1330 Rixensart / BE
	[2016/23]
Former [2013/20]	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
Inventor(s)	01 / GEALL, Andrew c/o Novartis Vaccines And Diagnostics Inc. P.O. Box 8097 Emeryville, CA 94662-8097 / US
	[2013/20]
Representative(s)	Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
	[N/P]
Former [2016/23]	Courgeon, Antoine GlaxoSmithKline Global Patents CN925.1 980 Great West Road Brentford, Middlesex TW8 9GS / GB
Former [2013/20]	Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB
Application number, filing date	11736497.6	06.07.2011
	[2016/23]
	WO2011US43096
Priority number, date	US20100361794P	06.07.2010 Original published format: US 361794 P
	[2013/20]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2012006369
	Date:	12.01.2012
	Language:	EN
	[2012/02]
	Type:	A2 Application without search report
	No.:	EP2591114
	Date:	15.05.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.01.2012 takes the place of the publication of the European patent application.
	[2013/20]
	Type:	B1 Patent specification
	No.:	EP2591114
	Date:	08.06.2016
	Language:	EN
	[2016/23]
Search report(s)	International search report - published on:	EP	23.08.2012
Classification	IPC:	C12N15/86, A61K39/00	[2013/20]
	CPC:	A61K39/155 (EP,US); C12N15/117 (US); A61K39/12 (EP,US); A61K39/39 (EP,US); A61K48/0041 (US); A61K48/0083 (US); (+) A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP,US); A61P33/00 (EP); A61P37/04 (EP,US); C12N15/86 (EP,US); A61K2039/53 (EP,US); A61K2039/552 (EP,US); A61K2039/55555 (EP,US); A61K2039/55566 (EP,US); C12N2760/18534 (EP,US); C12N2770/36143 (EP,US); C12N2820/60 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/20]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	IMMUNISIERUNG GROSSER SÄUGETIERE DURCH NIEDRIGE DOSEN VON RNA	[2015/46]
	English:	IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA	[2013/20]
	French:	IMMUNISATION DE GRANDS MAMMIFÈRES À L'AIDE DE FAIBLES DOSES D'ARN	[2013/20]
	Former [2013/20]	IMMUNISIERUNG VON GROSSEN SÄUGETIEREN MTI GERNGEN RNA-DOSEN
Entry into regional phase	06.02.2013	National basic fee paid
	06.02.2013	Designation fee(s) paid
	06.02.2013	Examination fee paid
Examination procedure	06.02.2013	Examination requested [2013/20]
	25.07.2013	Amendment by applicant (claims and/or description)
	28.11.2013	Despatch of a communication from the examining division (Time limit: M04)
	08.04.2014	Reply to a communication from the examining division
	02.05.2014	Despatch of a communication from the examining division (Time limit: M04)
	12.09.2014	Reply to a communication from the examining division
	05.01.2015	Despatch of a communication from the examining division (Time limit: M04)
	15.05.2015	Reply to a communication from the examining division
	12.06.2015	Despatch of a communication from the examining division (Time limit: M04)
	05.08.2015	Reply to a communication from the examining division
	20.11.2015	Communication of intention to grant the patent
	14.01.2016	Observations by third parties
	29.03.2016	Fee for grant paid
	29.03.2016	Fee for publishing/printing paid
	29.03.2016	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.11.2013
Opposition(s)	Opponent(s)	01 07.03.2017 10.03.2017 ADMISSIBLE Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL Opponent's representative Mewburn Ellis LLP, et al, et al Aurora Building Counterslip Bristol BS1 6BX / GB
		02 07.03.2017 10.03.2017 ADMISSIBLE Bayer Intellectual Property GmbH/Bayer Pharma Aktiengesellschaft/Bayer Animal Health GmbH Alfred-Nobel-Str. 10/Müllerstr. 178/ Kaiser-Wilhelm-Allee 10/ 40789 Monheim am Rhein/13353 Berlin/ 51373 Leverkusen/DE / DE Opponent's representative Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE
		03 08.03.2017 13.03.2017 ADMISSIBLE Müller, Christian Stefan Gerd ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE
		[N/P]
	Former [2019/11]
	Opponent(s)	01 07.03.2017 10.03.2017 ADMISSIBLE Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL Opponent's representative Mewburn Ellis LLP, et al, et al City Tower 40 Basinghall Street London EC2V 5DE / GB
		02 07.03.2017 10.03.2017 ADMISSIBLE Bayer Intellectual Property GmbH/Bayer Pharma Aktiengesellschaft/Bayer Animal Health GmbH Alfred-Nobel-Str. 10/Müllerstr. 178/ Kaiser-Wilhelm-Allee 10/ 40789 Monheim am Rhein/13353 Berlin/ 51373 Leverkusen/DE / DE Opponent's representative Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE
		03 08.03.2017 13.03.2017 ADMISSIBLE Müller, Christian Stefan Gerd ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE
	Former [2019/10]
	Opponent(s)	01 07.03.2017 10.03.2017 ADMISSIBLE Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL Opponent's representative Mewburn Ellis LLP, et al, et al City Tower 40 Basinghall Street London EC2V 5DE / GB
		02 07.03.2017 10.03.2017 ADMISSIBLE Bayer Intellectual Property GmbH/Bayer Pharma Aktiengesellschaft/Bayer Animal Health GmbH Alfred-Nobel-Str. 10/Müllerstr. 178/ Kaiser-Wilhelm-Allee 10/ 40789 Monheim am Rhein/13353 Berlin/ 51373 Leverkusen/DE / DE Opponent's representative Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE
		03 08.03.2017 13.03.2017 ADMISSIBLE Müller, Christian C/o ZSP Patantanwälte PartG mbB Radlkoferstr. 2 81373 Munich / DE
	Former [2017/15]
	Opponent(s)	01 07.03.2017 Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL Opponent's representative Jones, Rachel Ann, et al, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
		02 07.03.2017 ADMISSIBLE Bayer Intellectual Property GmbH/Bayer Pharma Aktiengesellschaft/Bayer Animal Health GmbH Alfred-Noble-Str. 10/Müllerstr. 178/ Kaiser-Wilhelm-Allee 10/ 40789 Monheim am Rhein/13353 Berlin/ 51373 Leverkusen/DE / DE Opponent's representative Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE
		03 08.03.2017 Müller, Christian C/o ZSP Patantanwälte PartG mbB Radlkoferstr. 2 81373 Munich / DE
	21.04.2017	Invitation to proprietor to file observations on the notice of opposition
	02.11.2017	Reply of patent proprietor to notice(s) of opposition
	08.10.2018	Date of oral proceedings
	27.11.2018	Despatch of interlocutory decision in opposition
	27.11.2018	Despatch of minutes of oral proceedings
	10.02.2023	Despatch of communication that the patent will be revoked
	20.02.2023	Legal effect of revocation of patent [2023/13]
Appeal following opposition	25.01.2019	Appeal received No. T0252/19
	08.04.2019	Statement of grounds filed
	06.02.2023	Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
	10.02.2023	Despatch of the decision of the Board of Appeal
	05.02.2019	Appeal received No. T0252/19
	05.04.2019	Statement of grounds filed
	06.02.2023	Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
	10.02.2023	Despatch of the decision of the Board of Appeal
	31.01.2019	Appeal received No. T0252/19
	05.04.2019	Statement of grounds filed
	06.02.2023	Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
	10.02.2023	Despatch of the decision of the Board of Appeal
	25.01.2019	Appeal received No. T0252/19
	04.04.2019	Statement of grounds filed
	06.02.2023	Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
	10.02.2023	Despatch of the decision of the Board of Appeal
Fees paid	Renewal fee
	10.07.2013	Renewal fee patent year 03
	14.07.2014	Renewal fee patent year 04
	10.07.2015	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	08.06.2016
	MC	08.06.2016
	MK	08.06.2016
	RS	08.06.2016
	SM	08.06.2016
	[2018/46]
Former [2018/31]	MC	08.06.2016
	MK	08.06.2016
	RS	08.06.2016
	SM	08.06.2016
Former [2017/23]	MC	08.06.2016
	RS	08.06.2016
	SM	08.06.2016
Former [2017/13]	RS	08.06.2016
	SM	08.06.2016
Former [2016/50]	RS	08.06.2016
Cited in	International search	[I]WO02061113 (UNIV JOHNS HOPKINS [US], et al);
	by applicant	WO0202606
		WO0234771
		WO03018054
		WO2005002619
		WO2005032582
		WO2005111066
		WO2005113782
		WO2005121348
		WO2006089264
		WO2006091517
		WO2006110413
		WO2006138004
		US2007014805
		WO2007049155
		WO2008020330
		US2008057080
		US2008085870
		WO2009016515
		WO2009031043
		WO2009104092
		WO2009109860
		WO2009132206
		WO2010119343
		WO2011005799
	Opposition	WO02061113
		WO2011005799
		US2011200667
		WO0000617
		WO0129233
		WO0226209
		WO02079239
		WO02095023
		WO2006078294
		WO2012006378
		WO2012006380
		WO2012030901
		US2003138453

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p